TipRanks
Go Ultimate55% OFF

Enovis (0I1B) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0I1B Analyst Ratings

Strong Buy
11Ratings
10Buy1Hold0Sell
Based on 11 analysts giving stock ratings to Enovis in the past 3 months

0I1B Stock 12 Month Forecast

$36.20▲(81.45% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Enovis in the last 3 months. The average price target is $36.20 with a high forecast of $47.00 and a low forecast of $27.00. The average price target represents a 81.45% change from the last price of $19.95.
Highest Price Target$47.00Average Price Target$36.20Lowest Price Target$27.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0I1B
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
Needham$52→$34buy70.43%UpsideReiterated10/12/26
UBS$51→$44buy120.55%UpsideReiterated10/05/26
BTIG$36buy80.45%UpsideReiterated10/02/26
Wells Fargo$33buy65.41%UpsideReiterated09/08/26
Citizens JMP$55→$47buy135.59%UpsideReiterated09/02/26
BMO Capital$30→$27buy35.34%UpsideAssigned09/01/26
Canaccord Genuity$45buy125.56%UpsideReiterated09/01/26
Freedom Capital Markets$41→$36buy80.45%UpsideReiterated09/01/26
William Blair―buy―Reiterated08/14/26
J.P. Morgan$28hold40.35%UpsideReiterated08/10/26
Evercore ISI$32buy60.40%UpsideReiterated08/07/26
Jefferies$40buy100.50%UpsideReiterated07/14/26
Robert W. Baird$45→$37buy85.46%UpsideReiterated05/08/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Enovis

3 Months
Jeff Johnson
Jeff JohnsonRobert W. Baird
Success Rate6/15 ratings generated profit
40%
Average Return
-2.19%

Copying Jeff Johnson's trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -2.19% per trade.

1 Year
Vijay Kumar
Vijay KumarEvercore ISI
Success Rate2/14 ratings generated profit
14%
Average Return
-17.60%

Copying Vijay Kumar's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -17.60% per trade.

2 Years
Success Rate2/18 ratings generated profit
11%
Average Return
-35.22%

Copying Michael Matson's trades and holding each position for 2 Years would result in 11.11% of your transactions generating a profit, with an average return of -35.22% per trade.

0I1B Analyst Recommendation Trends

010203040Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 0I1B
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy9971313
Buy45786
Hold00111
Sell00000
Strong Sell00000
total1314152220

In the current month, 0I1B has received 19 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 0I1B average Analyst price target in the past 3 months is 36.20.

0I1B Financial Forecast

$-1$-0.5$0$0.5$1Q4 2025Q2 2026Q3 2026
High$0.83
Consensus$0.77
Low$0.71

0I1B Earnings Forecast

Next quarter’s earnings estimate for 0I1B is $0.77 with a range of $0.71 to $0.83. The previous quarter’s EPS was $0.90. 0I1B beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0I1B has Performed in-line its overall industry.

$548.9M$559M$569M$579.1M$589.2MQ4 2025Q2 2026Q3 2026
High$563M
Consensus$557M
Low$552M

0I1B Sales Forecast

Next quarter’s sales forecast for 0I1B is $557.15M with a range of $552.30M to $563.00M. The previous quarter’s sales results were $582.78M. 0I1B beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0I1B has Performed in-line its overall industry.

0I1B Stock Forecast FAQ

What is GB:0I1B’s average 12-month price target, according to analysts?
Based on analyst ratings, Enovis’s 12-month average price target is $36.20.
What is GB:0I1B’s upside potential, based on the analysts’ average price target?
Enovis has 81.45% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Enovis a Buy, Sell or Hold?
Enovis has a consensus rating of Strong Buy, which is based on 10 buy ratings, 1 hold ratings and 0 sell ratings.
What is Enovis’s share price target?
The average share price target for Enovis is $36.20. This is based on 11 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $47.00, and the lowest forecast is $27.00. The average share price target represents a 81.45% increase from the current price of $19.95.
What do analysts say about Enovis?
Enovis’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Street analysts.
How can I buy shares of Enovis?
To buy shares of GB:0I1B, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.